Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Otsuka Beijing Research Institute, explained in plain language.
This study compares an oral drug (ASTX727) to an intravenous (IV) drug (decitabine) in 72 Chinese adults with myelodysplastic syndromes (MDS), a bone marrow disorder. Participants will receive both treatments in a crossover design to see if the pill works as well as the infusion.…
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Beijing Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC